Skip to content

July 2026: Government declines to widen the Thirlwall terms of reference (16 July) · new 100-page insulin report to the CCRC challenging the trial evidence (9 July) · Thirlwall report still expected no earlier than September · inquests relisted to 2027 · Shoo Lee Panel: no medical evidence of deliberate harm.

Lucy Letby Facts
Editorial summary (not a verbatim transcript)
·Dr Jim McCormack; Thirlwall Inquiry

Dr Jim McCormack — witness evidence (Thirlwall Inquiry)

Dr Jim McCormack, consultant, gave Thirlwall Inquiry evidence covering the wider clinical leadership at the Trust during the cluster period and the professional-college perspective on how the concerns should have been handled.

Last updated

Editorial summary — not a verbatim transcript.

This page is a summary written for this site. It is not a mirror of the primary document, and nothing on it should be quoted as the words of any person. An earlier version of this page carried quotations that could not be verified against the primary record; those have been removed. For the underlying record, consult the primary source at thirlwall.public-inquiry.uk. See our corrections policy.

Status: Editorial summary written for this site — not a mirrored document

Original source: thirlwall.public-inquiry.uk

Context

Dr Jim McCormack’s Thirlwall Inquiry evidence addresses the wider clinical-leadership layer at the Trust and the professional-college perspective on how concerns of the kind raised by the Countess of Chester consultants should have been handled under the clinical-governance norms of 2015-2016. His evidence bears on the question of whether the Trust’s response to the consultants’ September 2016 joint letter was consistent with then-current professional-body guidance or departed from it.

What the evidence addresses

  • The professional-college framework for handling clinical concerns escalated from consultant grade to Medical Director level at an NHS Foundation Trust.
  • The expected institutional response when consultants collectively identify a cluster of unexpected deaths and request police referral — as against the actual response (RCPCH service review commissioned instead).
  • The clinical-governance norms on escalation from Medical Director to CEO and from CEO to Board; the decision-chain documentation expected at each stage; and the record-keeping that should exist for audit purposes.
  • The leadership-layer perspective on why the eight-month delay between the September 2016 letter and the May 2017 police referral was an institutional failure.

Why this evidence matters

McCormack’s evidence provides the professional-college reference point against which the Thirlwall Inquiry will evaluate the Trust executive team’s specific decisions. If the Trust’s response departed from professional-college clinical-governance norms — and the evidence is substantially that it did — the Francis-framework and Morecambe-Bay parallels both apply.

Read alongside

Ian Harvey (Medical Director) witness evidence, RCPCH review authors, Ian Harvey — biography, Francis framework parallel, Morecambe Bay parallel.

Officials